Skyward Specialty Insurance price target raised to $80 from $75 at Citizens JMP

Citizens JMP analyst Matthew Carletti raised the firm’s price target on Skyward Specialty Insurance (SKWD) to $80 from $75 and keeps an Outperform rating on the shares. Skyward Specialty issued 2026 proforma guidance for the combined company following full approval of its Apollo acquisition, expected to close in early 1Q26, the analyst tells investors in a research note. The organization is positioned with a defensible portfolio of niche product lines that continue to benefit from strong macro tailwinds in the broader E&S and specialty markets, Citizens says.